11/17/2026 | Press release | Distributed by Public on 11/17/2026 12:38
WASHINGTON - U.S. Senate Democratic Whip Dick Durbin (D-IL), Ranking Member of the Senate Judiciary Committee, delivered an opening statement during today's Senate Judiciary Committee hearing entitled "Prescribing Sunshine: How Competition and Transparency Lowers Prescription Drug Costs." Today's hearing examined competition and transparency in the prescription drug supply chain, specifically consumers' lack of access to pharmacy services; how brand name drug companies' patent practices can inhibit competition from generics; and the role played by pharmacy benefit managers (PBMs) in drug pricing and access.
In his remarks, Durbin emphasized that Americans are paying the highest prescription drug prices in the world-on average four times more than people in similar countries for brand-name drugs. To address these sky-high prices and crack down on Big Pharma, Durbin advocated for the passage of his legislation with U.S. Senator Chuck Grassley (R-IA), the Drug-price Transparency for Consumers (DTC) Act, which would require price disclosures on advertisements for prescription drugs in order to empower patients and reduce Americans' colossal spending on medications.
Key Quotes:
"It is no secret: People in the United States pay the highest prescription drug prices in the world-on average, four times more than people in similar countries pay for brand-name drugs. Patients are forced to choose between [prescription] drugs and food."
"Compounding this challenge is the lack of access to brick-and-mortar pharmacies. In the last 15 years, more than 800 community pharmacies in my state of Illinois have been forced to close their doors because of increased drug costs and declining reimbursement rates."
"Congress took a first step forward to address the high cost of [prescription] drugs by passing the Inflation Reduction Act in 2022. This law capped the price of insulin at $35 per month. It set an annual out-of-pocket expense limit for seniors-$2,100 in 2026. It also let the executive branch negotiate with Big Pharma to lower prices under Medicare-something President Biden used to reduce drug prices by up to 79 percent."
"There's more work to do. Where should we start? Let me suggest, direct-to-consumer drug ads. There are only two countries in the world that allow consumer television ads for drugs… Big Pharma spends billions of dollars to flood the airwaves with advertisements. Why? To get American viewers to get to the point where they can not only pronounce Xarelto but spell it."
"In July, a citizen petition was filed with the FDA asking to ban these ads… If we cannot get rid of them, we should at least require Big Pharma to let people know how much these drugs cost. Is that an outrageous idea?"
"Chairman Grassley and I have a simple bill that we put together that would require direct-to-consumer ads to disclose the price charged by the drug company. It's a basic transparency issue to inform patients, and it's been supported by President Trump in the past. I hope we pass it before the end of the year."
"We must also address Big Pharma's anti-competitive schemes to maintain monopolies. The Senate Judiciary Committee has taken a leading role in stopping these abuses. In April 2025, this Committee unanimously reported six bipartisan bills to address this issue. This includes my bill with Republican Senator Tillis to improve information sharing between the FDA and Patent Office. Congress must pass these bills sooner rather than later."
"This hearing is going to make clear that our work to address the high cost of prescription drugs is far from over. Let's work together, on a bipartisan basis, to do something to help families afford their prescription drugs."
Video of Durbin's opening statement is available here.
Audio of Durbin's opening statement is available here.
Footage of Durbin's opening statement is available here for TV Stations.
-30-